Targeting hTERT Promoter G-Quadruplex DNA Structures with Small-Molecule Ligand to Downregulate hTERT Expression for Triple-Negative Breast Cancer Therapy
Journal of Medicinal Chemistry · 08.08.2024 · 67 (15) · 13363-13382
DOI: 10.1021/acs.jmedchem.4c01255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.07.2024. Verfasst von Wei Long und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic Univers…. Hauptthemen laut MEDLINE: Telomerase, G-Quadruplexes, Triple Negative Breast Neoplasms, Promoter Regions, Genetic. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Research Grants Council, University Grants Committee, Hong Kong Polytechnic University.
Abstract (Originalsprache)
Human telomerase reverse transcriptase (hTERT) may have noncanonical functions in transcriptional regulation and metabolic reprogramming in cancer cells, but it is a challenging target. We thus developed small-molecule ligands targeting hTERT promoter G-quadruplex DNA structures (hTERT G4) to downregulate hTERT expression. Ligand 5 showed high affinity toward hTERT G4 (Kd = 1.1 μM) and potent activity against triple-negative breast cancer cells (MDA-MB-231, IC50 = 1 μM). In cell-based assays, 5 not only exerts markedly inhibitory activity on classical telomere functions including decreased telomerase activity, shortened telomere length, and cellular senescence but also induces DNA damage, acute cellular senescence, and apoptosis. This study reveals that hTERT G4-targeting ligand may cause mitochondrial dysfunction, disrupt iron metabolism and activate ferroptosis in cancer cells. The in vivo antitumor efficacy of 5 was also evaluated in an MDA-MB-231 xenograft mouse model and approximately 78.7% tumor weight reduction was achieved. No observable toxicity against the major organs was observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR 999077, China.
- State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China.
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology Guangzhou 510006, China.
ORCID-Profile: Wing-Leung Wong
Förderung
- Research Grants Council, University Grants Committee
- Hong Kong Polytechnic University
Zitieren
APA
Long, W., Zeng, Y. X., Zheng, B. X., Li, Y. B., Wang, Y. K., Chan, K. H., She, M. T., Lu, Y. J., Cao, C., & Wong, W. L. (2024). Targeting hTERT Promoter G-Quadruplex DNA Structures with Small-Molecule Ligand to Downregulate hTERT Expression for Triple-Negative Breast Cancer Therapy. Journal of Medicinal Chemistry, 67(15), 13363-13382. https://doi.org/10.1021/acs.jmedchem.4c01255
Vancouver
Long W, Zeng YX, Zheng BX, Li YB, Wang YK, Chan KH, et al. Targeting hTERT Promoter G-Quadruplex DNA Structures with Small-Molecule Ligand to Downregulate hTERT Expression for Triple-Negative Breast Cancer Therapy. Journal of Medicinal Chemistry. 2024;67(15):13363-13382. doi:10.1021/acs.jmedchem.4c01255
BibTeX
@article{Long2024,
author = {Long, Wei and Zeng, Yao-Xun and Zheng, Bo-Xin and Li, Yu-Bo and Wang, Ya-Kun and Chan, Ka-Hin and She, Meng-Ting and Lu, Yu-Jing and Cao, Chunyang and Wong, Wing-Leung},
title = {Targeting hTERT Promoter G-Quadruplex DNA Structures with Small-Molecule Ligand to Downregulate hTERT Expression for Triple-Negative Breast Cancer Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {15},
pages = {13363--13382},
doi = {10.1021/acs.jmedchem.4c01255}
}
EUVIMED